- Home
- SRL vs OPTN Comparison
SRL vs OPTN Comparison
Compare SRL & OPTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRL
- OPTN
- Stock Information
- Founded
- SRL 2017
- OPTN 2010
- Country
- SRL China
- OPTN United States
- Employees
- SRL N/A
- OPTN N/A
- Industry
- SRL Professional Services
- OPTN Biotechnology: Pharmaceutical Preparations
- Sector
- SRL Consumer Discretionary
- OPTN Health Care
- Exchange
- SRL Nasdaq
- OPTN Nasdaq
- Market Cap
- SRL 121.2M
- OPTN 99.7M
- IPO Year
- SRL N/A
- OPTN 2017
- Fundamental
- Price
- SRL $7.93
- OPTN $0.46
- Analyst Decision
- SRL
- OPTN Strong Buy
- Analyst Count
- SRL 0
- OPTN 3
- Target Price
- SRL N/A
- OPTN $3.00
- AVG Volume (30 Days)
- SRL 8.1K
- OPTN 617.5K
- Earning Date
- SRL 12-09-2024
- OPTN 11-12-2024
- Dividend Yield
- SRL N/A
- OPTN N/A
- EPS Growth
- SRL N/A
- OPTN N/A
- EPS
- SRL 0.07
- OPTN N/A
- Revenue
- SRL $41,604,386.00
- OPTN $75,672,000.00
- Revenue This Year
- SRL N/A
- OPTN $24.44
- Revenue Next Year
- SRL N/A
- OPTN $49.00
- P/E Ratio
- SRL $115.04
- OPTN N/A
- Revenue Growth
- SRL N/A
- OPTN 5.13
- 52 Week Low
- SRL $4.09
- OPTN $0.44
- 52 Week High
- SRL $8.59
- OPTN $2.10
- Technical
- Relative Strength Index (RSI)
- SRL 40.80
- OPTN 28.38
- Support Level
- SRL $7.65
- OPTN $0.50
- Resistance Level
- SRL $8.13
- OPTN $0.81
- Average True Range (ATR)
- SRL 0.27
- OPTN 0.06
- MACD
- SRL -0.03
- OPTN -0.02
- Stochastic Oscillator
- SRL 0.00
- OPTN 3.23
About SRL Scully Royalty Ltd.
Scully Royalty Ltd is a royalty-based company that maximizes earnings upon its iron ore royalty interest. The company's business segments include Royalty, which includes an interest in an iron ore mine; Industrial, which includes projects in resources and services; Merchant Banking, which comprises regulated merchant banking activities; and others. The majority of the revenue is generated from the Royalty segment. The company's geographical segments include Canada, Africa, America, Asia, and Europe, out of which Canada accounts for the majority of the revenue.
About OPTN OptiNose Inc.
OptiNose Inc is a specialty pharmaceutical company that focuses on the development and commercialization of products for patients treated by ear, nose, and throat, and allergy specialists. Its product includes XHANCE (fluticasone propionate) nasal spray, 93 micrograms, a therapeutic utilizing its proprietary Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps. The XHANCE is able to deliver medication to the primary site of inflammation high and deep in the nasal passages in regions not adequately reached by intranasal steroids.